Unknown

Dataset Information

Nano-ellagic acid: inhibitory actions on aldose reductase and α-glucosidase in secondary complications of diabetes, strengthened by in silico docking studies.


ABSTRACT: Increased blood sugar levels in prolonged diabetes lead to secondary complications such as retinopathy, neuropathy, and nephropathy, which gradually end in death. Synthesis of nano-phytomedicines from active phytoconstituents for novel emerging applications in the field of pharmaceuticals is of huge interest among researchers. In the present investigation, encapsulated ellagic acid (NEA) was synthesized at four different concentrations (0.2%, 0.3%, 0.4%, 0.5%) using ZnO nanoparticles as encapsulating agent. The surface morphology (fiber-like structures) of the nanoparticles were determined by scanning electron microscopy (SEM) and particle size (161-297 nm) and zeta potential (- 54.9-38.4 mV) were determined by dynamic light scattering technique. Further, the α-glucosidase and aldose reduc

SUBMITTER: Marella S 

PROVIDER: S-EPMC7498530 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature